Submission | General Principles | Study Ethics | Publication ethics | Clinical Trial Registration | Structure and Language | Title Page and Authorship | Abstract and Keywords | Main Text | Abbreviations | Conflict of Interest | Acknowledgment | Funding Sources | Tables and Figures | Units of Measurement | References | Copyright Licenses | Publication Fee
The submitted manuscript should be addressed to Editor-in-chief of the Medical Journal of Indonesia. Manuscript must be submitted through online submission by registered users. You can easily register in the journal system. For further questions contact us at email@example.com.
As a basic requirement, all articles submitted to the Medical Journal of Indonesia must be original work, which has never been published previously and is submitted exclusively to the Medical Journal of Indonesia. They must be written in the format of “Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals” (http://www.icmje.org/), which was established by the International Committee of Medical Journal Editors (ICMJE) and updated in December 2018. The Editorial Board reserves the right to edit all articles in aspects of style, format, and clarity. Authors may be required to revise their manuscripts for reasons of any aspect. Manuscripts with excessive errors in any aspect may be returned to authors for retyping or may be rejected. All manuscripts will be subjected to peer and editorial review.
We accept four types of articles: (1) original articles: basic medical research, clinical research, or community research; (2) case report; (3) review article; (4) brief communication. Basic medical research covers in vitro research or animal studies. Clinical research covers studies done in human subjects. Community research covers studies done in the community and related to health policy. Case reports cover interesting reports of single case and case series that also provides some statistical analysis. Review articles include systematic and narrative reviews that have novelty in a medical field. Brief communications includes preliminary reports and manuscript that do not cover the above categories but are still related to and have an important impact on medical research and health policy.
Authors must also supply:
- ICMJE conflicts of interest statement form (if there are any difficulties in accessing the form, you can directly visit here,
- copy of ethical approval (when needed), and
- final checklist signed by all author(s).
A cover letter should be provided along with the submission addressed to the Editor-in-chief of Medical Journal of Indonesia which should include a statement about all previous submissions of the manuscript and previous reports that might be regarded as redundant publication of the work. If the manuscript has been submitted previously to another journal, authors are encouraged to provide previous comments along with the responses to accelerate the review process. Author(s) also have to mention the work whether it has been presented in a congress/conference/seminar.
All submitted papers containing animal experiments and/or involving human subjects should have obtained approval from an independent ethics committee. The copy of approval should be provided to the editorial office as mentioned above.
The publisher of this journal is a member of Committee on Publication Ethics (COPE). This journal follows guidelines from COPE in facing all aspects of publication ethics and, in particular, how to handle cases of research and publication misconduct. All articles in this journal involving human subjects should respect principles of research ethics as described in the Declaration of Helsinki and studies involving animals should obey the International Guiding Principles for Biomedical Research as developed by the Council for International Organization of Medical Sciences (CIOMS).
Medical Journal of Indonesia adapts COPE principle to meet high quality standard of ethics for publisher, editors, authors, and reviewers. As an essential issue, publication ethics need to be explained clearly to improve the quality of research worldwide. In this part, we explain the standard for editors, authors, and reviewers. In addition, publisher does not have the right to interfere with the integrity of the contents and only support to publish in timely manner.
Clinical Trial Registration
The authors are encouraged to register all clinical trials to the publicly accessible registration in any registry as recommended by ICMJE or integrated to WHO International Clinical Trials Registry Platform (ICTRP) or in ClinicalTrials.gov, which is a data provider to the WHO ICTRP. The trial registration number should be provided at the end of the abstract. The registration should be done prior to the conduct of the trial.
Structure and Language
Articles will be published in US English, following American spelling. Articles in English that are linguistically inadequate may be rejected. Manuscripts should be written double-spaced in all parts of the manuscript using Times New Roman 12, with margin of 2.54 cm of all sides. Articles must be submitted in the following structural order: title page and authorship, abstract, keywords, text, conflicts of interest, acknowledgments (if any), funding disclosure, references, tables, figures, and legends (if any).
Abstract and Keywords
The abstract should be formally structured and prepared in English with a maximum of 250 words for biomedical, clinical, and community research articles and systematic review or meta analysis; for case reports, brief communications, and narrative reviews, the abstract should not be structured formally and should not exceed a maximum of 150 words. Abstracts should be concise and precise with enough information, highlighting the points and importance of the article. It should contain: background and purpose of the study; methods (basic procedures, study subject selection, observational or analytical methods); main findings or results; and principal conclusion. Keywords are limited to 3 - 6 words or short phrases that will allow proper and convenient indexing. They should be obtained from Medical Subject Headings (MeSH®) thesaurus produced by National Library of Medicine.
The main text should be structured as introduction, methods, results, and discussion (IMRAD). Methods should provide clarity about how, why, and when the study was done. The methods section should include the statement of approval by local, regional, or national review board. It should also clearly describe the selection of the study’s participants. Materials and equipment used should be identified in methods section by specifically giving the manufacturer’s name and address in parentheses. References to all established methods must be given. All statistical methods used should be described in detail in the methods section of the manuscript. Relying solely on statistical hypothesis testing, such as p values should be avoided; instead, important information about effect size and precision of estimates should be provided. Statistical terms, abbreviations, and symbols should be defined and computer software and version used should be specified. In the results section, data should be presented in a concise and precise way, either in figures or tables, but not the same finding in a figure and a table. Unnecessary figures and tables, as well as footnotes should be avoided and their contents incorporated into the text. In the last sentence of the discussion a conclusion should be stated.
Use only standard abbreviations; use of nonstandard abbreviations can be confusing to readers. Avoid abbreviations in the title of the manuscript. When first mentioned, all abbreviations must be spelled out followed by the abbreviation in parenthesis, unless the abbreviation is a standard unit of measurement. Since the abstract is a separate entity by its own, abbreviations must be spelled out in the abstract and repeated when first mentioned in the main text. If a sentence begins with a number, it should be spelled out.
Conflicts of Interest
Conflicts of interest should be transparent as detail as possible as provided in the ICMJE form as a standardized authors’ disclosures. Financial and personal relationships are easily identifiable that might bias or be seen to bias the work. Funding sources for the work should be described specifically with explanations of the role of those sources and the authors should declare that the supporting sources had no involvement in specific role. The authors should declare that the authors had access to all the study and the sponsors did not intervene the data or the work. Each author should submit a separate form from ICMJE.
Personal acknowledgments should be limited to appropriate proffesionals who contributed to the paper, including technical help and financial or material support, also general support by a department chairperson.
Funding sources for the work should be described specifically with explanations of the role of those sources and the authors should declare that the supporting sources had no involvement into nor influence on the content of the manuscript. This statement should be written separately and limited to the funding for the work. If funder(s) had any impact into or influence on the design; data collection, management, analysis and interpretation of the data, the preparation, review, or approval of the manuscript or the decision to submit the manuscript for publication, their role must be disclosed in detail.
Tables and Figures
Total number of tables and figures are advisable not to exceed 6 in number. Tables and its title should be presented in separate sheets. Tables should be numbered in Arabic numerals, captions should be brief, clearly indicating the purpose or content of each table. Provide a footnote to each table, identifying in alphabetical order all abbreviations used. Number tables consecutively in the order of their first citation in the text and supply a brief title for each. Do not use internal horizontal or vertical lines. Give each column a short or an abbreviated heading. Explain all nonstandard abbreviations and explanatory matters in footnotes, and for explanatory matters use the following symbols, in sequence: *, †, ‡, §, ¶, **, ††, ‡‡, §§, ¶¶, etc. Identify statistical measures of variations, such as standard deviation and standard error of the mean. Be sure that each table is cited in the text. If you use data from another published source, obtain permission and acknowledge that source fully.
Figures should be either professionally drawn or photographed, and submitted in a format (JPEG or TIFF) in the following resolutions [gray-scale or color in RGB (red, green, blue mode) at least 300 dpi (dots per inch). For x-ray films, scans, and other diagnostic images, as well as pictures of pathology specimens or photomicrographs, send sharp, glossy, black-and-white or color photographic prints, usually 127 x 173 mm (5 x 7 inches). Write the word “top” on the back of each figure at the appropriate place. Figures should be made as self-explanatory as possible, titles and detailed explanations belong in the legends-not on the figures themselves. Photomicrographs should have internal scale markers. Symbols, arrows, or letters used in photomicrographs should contrast with the background. When symbols, arrows, numbers, or letters are used to identify parts of the illustrations, identify and explain each one clearly in the legend. Explain the internal scale and identify the method of staining in photomicrographs. Photographs of potentially identifiable people must be accompanied by written permission to use the photograph.
Tables and figures should be numbered consecutively according to the order in which they have been cited in the text. If a table or figure has been published previously, acknowledge the original source and submit written permission from the copyright holder to reproduce it. Permission is required irrespective of authorship or publisher except for documents in the public domain using license of CC BY SA. Color figures are allowed in special circumstances, provided that the author is willing to cover the cost of reproduction. If the original size of the figures is too large, you can provide us lower quality figures on submission and ensure the availability of good quality figures after the acceptance of the manuscript.
Units of Measurement
For measurements use both local and S.I. (System International) units. Measurements should be abbreviated (e.g. mm, kcal, etc.) in accordance with the Style Manual for Biological Sciences and using the metric system. Measurements of length, height, weight, and volume should be reported in appropriate scientific units. Temperatures should be in degrees Celsius. Blood pressures should be in millimeters of mercury (mmHg). Drug concentrations may be reported in either SI or mass units, but the alternative should be provided in parentheses where appropriate.
Use Arabic numerals in supercript to cite references in National of Medicine style. References are advisably not to exceed 25 in number but not less than 10, and should in general be limited to the last decade, except for references to methods used: they must be cited no matter how old they are. More than 25 references may be accepted when it is necessary. References must be numbered in the order in which they are mentioned in the text. Use the style of the examples below, which are based on the International Committee of Medical Journal Editors (ICMJE) Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals: Sample References. The titles of journals should be abbreviated according to the style used for MEDLINE. Avoid using abstracts as references. Information from manuscripts submitted but not yet accepted should be cited in the text as “unpublished observations” with written permission from the source. Papers accepted but not yet published may be included as references; designate the journal and add “Forthcoming”. Avoid citing “personal communication” unless it provides essential information not available publicly, name the person and date of communication, obtain written permission and confirmation of accuracy from the source of personal communication. Authors are recommended to use reference management software, in writing the citations and references such as: Mendeley®, Zotero®, EndNote®, and Reference Manager®.
Here are some examples of the references:
1. Standard journal article
Up to six authors, list all the authors.
- Halpern SD, Ubel PA, Caplan AL. Solid-organ transplantation in HIV-infected patients. N Engl J Med. 2002 Jul 25;347(4):284-7.
More than six authors, list the first six authors, followed by et al.
- Rose ME, Huerbin MB, Melick J, Marion DW, Palmer AM, Schiding JK, et al. Regulation of interstitial excitatory amino acid concentrations after cortical contusion injury. Brain Res. 2002;935(1-2):40-6.
Optional addition of a database’s unique identifier for the citation: [Edited 12 May 2009]
- Halpern SD, Ubel PA, Caplan AL. Solid-organ transplantation in HIV-infected patients. N Engl J Med. 2002 Jul 25;347(4):284-7. PubMed PMID: 12140307.
- Forooghian F, Yeh S, Faia LJ, Nussenblatt RB. Uveitic foveal atrophy: clinical features and associations. Arch Ophthalmol. 2009 Feb;127(2):179-86. PubMed PMID: 19204236; PubMed Central PMCID: PMC2653214.
Optional addition of a clinical trial registration number: [Added 12 May 2009]
- Trachtenberg F, Maserejian NN, Soncini JA, Hayes C, Tavares M. Does fluoride in compomers prevent future caries in children? J Dent Res. 2009 Mar;88(3):276-9. PubMed PMID: 19329464. ClinicalTrials.gov registration number: NCT00065988.
As an option, if a journal carries continuous pagination throughout a volume (as many medical journals do) the month and issue number may be omitted.
- Halpern SD, Ubel PA, Caplan AL. Solid-organ transplantation in HIV-infected patients. N Engl J Med. 2002;347:284-7.
2. Chapter in a book
Meltzer PS, Kallioniemi A, Trent JM. Chromosome alterations in human solid tumors. In: Vogelstein B, Kinzler KW, editors. The genetic basis of human cancer. New York: McGraw-Hill; 2002. p. 93-113.
3. Homepage/Web site [Edited 12 May 2009]
Cancer-Pain.org [Internet]. New York: Association of Cancer Online Resources, Inc.; c2000-01 [updated 2002 May 16; cited 2002 Jul 9]. Available from: http://www.cancer-pain.org/.
Authors who publish with Medical Journal of Indonesia agree to the following terms:
- Authors retain copyright and grant Medical Journal of Indonesia right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial License (http://creativecommons.org/licenses/by-nc/4.0/) that allows others to remix, adapt, build upon the work non-commercially with an acknowledgement of the work’s authorship and initial publication in Medical Journal of Indonesia.
- Authors are permitted to copy and redistribute the journal’s published version of the work non-commercially (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in Medical Journal of Indonesia.
This journal only charges the article publication fee for all manuscript types, without any submission fee. The publication fee is US$ 300 for foreign authors and IDR 3,000,000,- for Indonesian authors. For each printed page that contains colored figure, you will be asked to pay US$ 50 (IDR 500,000,-) each printed page more.When the accepted manuscript has been proofread by the authors, Medical Journal of Indonesia office will send the invoice to the corresponding author and they need to complete the payment process before being published. To enhance the research in health programme, Medical Journal of Indonesia will cover the publication fee of authors from the countries that are included in group A and group B countries of HINARI by WHO. Waiver of payment is not only limited to those countries. All authors may ask a waive, and they need to send letter of waiver to editor-in-chief explaining the importance of the study and why author(s) need to be waived. The decision is made prior to the process of the review and it is the editors’ priviledge to approve or reject the request.
Updated - March 2019